Condition
T-Cell Dysfunction
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
3 treatments under study, led by Fasting
Related Conditions
Often studied with 5 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06684054Not Yet RecruitingPrimary
Studying the Senescent T Cell Features and Its Relationship with the Chemotherapy Efficacy in Young TNBC
NCT05886738Not ApplicableUnknown
Investigating the Effect of Short-term Fasting on T Cell Metabolism, Function, and Phenotype in Obesity
NCT04658069Unknown
T Cell Dysfunction in ESRD
Showing all 3 trials
Research Network
Common Treatments
- Fasting1
- Docetaxel Anthracycline Cyclophosphamide1
- No Specific Interventions1
Active Sponsors
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1
- University of British Columbia1
- Shanghai Zhongshan Hospital1
Top Investigators
Fudan University
Fudan University
Related Conditions
- Chemotherapy Effect1
- Obesity1
- Fasting1
- Adverse Events1
- Esrd1